An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans
The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
An engineered E. coli strain lowers blood ammonia, improves survival in models of hyperammonemia, and demonstrates safety in healthy volunteers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Engineered LBPs can be designed to perform natural biological processes, such as the assimilation of ammonia into amino acids, at significantly increased rates14 and to produce effectors that are not native to bacteria, including human proteins16.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [14]
In the citing paper
“Currently, non-colonizing engineered organisms require frequent dosing, as the residence time of the strain is short in the body14.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [14]
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 3×
“M. I. Love, W. Huber, S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.”
InfluentialTrimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
KEGG as a reference resource for gene and protein annotation
Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1070 · Cited by 7,387
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Vilstrup, H., Amodio, P., Bajaj, J., Cordoba, J., Ferenci, P., Mullen, K. D., Weissenborn, K., & Wong, P. (2014) · Hepatology · doi:10.1002/hep.27210 · Cited by 2,056 · cited 1×
“HE occurs in 30 to 40% of patients with cirrhosis (24).”
BackgroundGut microbiota in cardiovascular health and disease
Tang, W. H. W., Kitai, T., & Hazen, S. L. (2017) · Circulation Research · doi:10.1161/circresaha.117.309715 · Cited by 1,670 · cited 1×
“The mammalian intestinal tract is inhabited by a dense commu nity of microorganisms and is a possible target for the development of a new class of live microbial therapeutics designed to modulate toxic dietary or endogenous gutderived metabolites (8, 9).”
BackgroundTreatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513
Microbial ureases: significance, regulation, and molecular characterization.
Mobley, H. L., & Hausinger, R. P. (1989) · Microbiological Reviews · doi:10.1128/mmbr.53.1.85-108.1989 · Cited by 1,507
Rifaximin Treatment in Hepatic Encephalopathy
Bass, N. M., Mullen, K. D., Sanyal, A., Poordad, F., Neff, G., Leevy, C. B., Sigal, S., Sheikh, M. Y., Beavers, K., Frederick, T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907893 · Cited by 1,300 · cited 1×
“Those drugs include the antibiotic rifaximin, which may reduce activity of ureaseproducing bacteria, and the laxative lactulose, a nonabsorbable disaccharide that acidifies the colon and decreases transit time, resulting in increased fecal elimination of ammonia (34).”
BackgroundKruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285
Rembacken, B., Snelling, A., Hawkey, P., Chalmers, D., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,101
The RpoS-Mediated General Stress Response in Escherichia coli
Battesti, A., Majdalani, N., & Gottesman, S. (2011) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102946 · Cited by 918 · cited 1×
“coli, rpoS (56), heatshock protein genes [dnaKJE and groELS (57)], and multiple acid resistance genes [the glutamate decarboxylase genes gadA and gadB (58) and the glutaminase gene glsA (55)].”
BackgroundImmune responses to Listeria monocytogenes
Pamer, E. G. (2004) · Nature Reviews Immunology · doi:10.1038/nri1461 · Cited by 794 · cited 1×
“Some studies with Listeria monocytogenes strains engineered as vaccines for various cancers have also been evaluated (64).”
BackgroundUptake and Metabolism of Plasma Glutamine by the Small Intestine
Windmueller, H. G., & Spaeth, A. E. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42329-6 · Cited by 790
A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease
Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J., van Deventer, S. J. H., Neirynck, S., Peppelenbosch, M. P., & Steidler, L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.028 · Cited by 786
KRUIS, W., SCHÜTZ, E., FRIC, P., FIXA, B., JUDMAIER, G., & STOLTE, M. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00225.x · Cited by 775
The Epidemiology of Cirrhosis in the United States: A Population-based Study
Scaglione, S., Kliethermes, S., Cao, G., Shoham, D., Durazo, R., Luke, A., & Volk, M. L. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000208 · Cited by 683 · cited 1×
“27% of the population or 633,323 adults (25).”
BackgroundClemmesen, J. O., Larsen, F. S., Kondrup, J., Hansen, B. A., & Ott, P. (1999) · Hepatology · doi:10.1002/hep.510290309 · Cited by 669 · cited 1×
“The pathogenesis of HE is be lieved to be largely attributable to hyperammonemia and inflam matory processes associated with damage to the liver (27, 28).”
BackgroundLiu, Q., Duan, Z. P., Ha, D. K., Bengmark, S., Kurtovic, J., & Riordan, S. M. (2004) · Hepatology · doi:10.1002/hep.20194 · Cited by 638 · cited 1×
“Nau sea and vomiting at the highest doses (single and multiple doses of 2 × 1012 CFU and one subject administered 5 × 1011 CFU) were ob served and have been reported in clinical trials for other microbiome based treatments delivered to the upper intestinal tract (72, 74, 75).”
MethodSuggested guidelines for the diagnosis and management of urea cycle disorders
Häberle, J., Boddaert, N., Burlina, A., Chakrapani, A., Dixon, M., Huemer, M., Karall, D., Martinelli, D., Crespo, P., Santer, R., et al. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-32 · Cited by 628 · cited 7×
“UCDs are rare but serious and potentially fatal genetic diseases characterized by a deficiency in one of the six enzymes or two transporters necessary for the urea cycle to effectively metabolize waste nitrogen to urea (21).”
BackgroundInfluentialCharbonneau, M. R., O’Donnell, D., Blanton, L. V., Totten, S. M., Davis, J. C. C., Barratt, M. J., Cheng, J., Guruge, J., Talcott, M., Bain, J. R., et al. (2016) · Cell · doi:10.1016/j.cell.2016.01.024 · Cited by 606 · cited 1×
“Any TEAE 0 0 0 2 (67) 1 (33) 1 (33) 2 (67) 0 5 (83) 2 (33) 0 1 (17)”
Self-citationIsabella, V. M., Ha, B. N., Castillo, M. J., Lubkowicz, D. J., Rowe, S. E., Millet, Y. A., Anderson, C. L., Li, N., Fisher, A. B., West, K. A., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4222 · Cited by 605
Self-citationCorrelation between ammonia levels and the severity of hepatic encephalopathy
Ong, J. P., Aggarwal, A., Krieger, D., Easley, K. A., Karafa, M. T., Van Lente, F., Arroliga, A. C., & Mullen, K. D. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01477-8 · Cited by 538 · cited 1×
“Increased arterial and venous ammonia concentrations correlated with increased HE severity, with concentrations above 100 M in addition to model for endstage liver disease (MELD) scores above 32 that are predictive of an onset of an episode of HE with 94% specificity and 74% accuracy (29, 30).”
BackgroundThe heat shock response of Escherichia coli
Arsène, F., Tomoyasu, T., & Bukau, B. (2000) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(00)00206-3 · Cited by 500
Engineering bacteria for diagnostic and therapeutic applications
Riglar, D. T., & Silver, P. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.172 · Cited by 460 · cited 1×
“Although several engineered bacteria and probiotic strains have been created and tested in preclinical models (61), few have progressed into clinical development.”
BackgroundMorris, S. M. (2016) · The Journal of Nutrition · doi:10.3945/jn.115.226621 · Cited by 435 · cited 2×
“Our inability to detect such a biomarker may be due to the complex and rapid metabolism of arginine to a large number of products such as ornithine, citrulline, nitric oxide (further oxidized to nitrate and excreted in urine), urea, creatine, agmatine, polyamines, proline, and others (77).”
BackgroundWalser, M., & Bodenlos, L. J. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103940 · Cited by 429
Zyrek, A. A., Cichon, C., Helms, S., Enders, C., Sonnenborn, U., & Schmidt, M. A. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00836.x · Cited by 428
Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation
Riglar, D. T., Giessen, T. W., Baym, M., Kerns, S. J., Niederhuber, M. J., Bronson, R. T., Kotula, J. W., Gerber, G. K., Way, J. C., & Silver, P. A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3879 · Cited by 426
Self-citationSystematic Review: Adverse Events of Fecal Microbiota Transplantation
Wang, S., Xu, M., Wang, W., Cao, X., Piao, M., Khan, S., Yan, F., Cao, H., & Wang, B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161174 · Cited by 409
Interorgan Amino Acid Transport and its Regulation
Brosnan, J. T. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.6.2068s · Cited by 347 · cited 1×
“Small intestinal ammo nia arises from the deamidation of glutamine within intestinal epi thelial cells (14, 15), whereas bacterial degradation of protein and microbial urease activity generates ammonia in the colon (16, 17).”
BackgroundDhiman, R. K., Rana, B., Agrawal, S., Garg, A., Chopra, M., Thumburu, K. K., Khattri, A., Malhotra, S., Duseja, A., & Chawla, Y. K. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.031 · Cited by 339 · cited 1×
“It has been reported that fasting ammo nia levels were decreased in cirrhotic patients treated with probiotic VSL#3, whereas ammonia increased in patients receiving placebo (70).”
BackgroundThomason, M. K., Bischler, T., Eisenbart, S. K., Förstner, K. U., Zhang, A., Herbig, A., Nieselt, K., Sharma, C. M., & Storz, G. (2015) · Journal of Bacteriology · doi:10.1128/jb.02096-14 · Cited by 335
Yamashiro, K., Tanaka, R., Urabe, T., Ueno, Y., Yamashiro, Y., Nomoto, K., Takahashi, T., Tsuji, H., Asahara, T., & Hattori, N. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171521 · Cited by 314 · cited 1×
“The mammalian intestinal tract is inhabited by a dense commu nity of microorganisms and is a possible target for the development of a new class of live microbial therapeutics designed to modulate toxic dietary or endogenous gutderived metabolites (8, 9).”
BackgroundPathogenesis of Hepatic Encephalopathy: Role of Ammonia and Systemic Inflammation
Aldridge, D. R., Tranah, E. J., & Shawcross, D. L. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.06.004 · Cited by 313 · cited 2×
“The longstanding evidence for the importance of intestinally generated ammonia and the observation that antibiotic treatment can lower systemic and portal ammonia (31–33) have led to the clinical development of therapeutic agents aimed at decreasing gut microbial activity or adsorbing colonic ammonia for the treatmen…”
BackgroundExperimental models of hepatic encephalopathy: ISHEN guidelines
Butterworth, R. F., Norenberg, M. D., Felipo, V., Ferenci, P., Albrecht, J., Blei, A. T., & Members of the ISHEN Commission on Experimental Models of HE (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02034.x · Cited by 294 · cited 1×
“We also used the TAAbased hepatic injury model in wildtype Balb/c mice, an accepted preclinical model of HE, as a second model of systemic hyperammonemia (69).”
MethodDuan, F. F., Liu, J. H., & March, J. C. (2015) · Diabetes · doi:10.2337/db14-0635 · Cited by 263
Covert and Overt Hepatic Encephalopathy: Diagnosis and Management
Patidar, K. R., & Bajaj, J. S. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.06.039 · Cited by 235 · cited 1×
“The pathogenesis of HE is be lieved to be largely attributable to hyperammonemia and inflam matory processes associated with damage to the liver (27, 28).”
BackgroundThe non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic
Sonnenborn, U., & Schulze, J. (2009) · Microbial Ecology in Health and Disease · doi:10.3109/08910600903444267 · Cited by 232
THYMINE METABOLISM AND THYMINELESS DEATH IN PROKARYOTES AND EUKARYOTES
Ahmad, S. I., Kirk, S. H., & Eisenstark, A. (1998) · Annual Review of Microbiology · doi:10.1146/annurev.micro.52.1.591 · Cited by 229
Deoxythymidine Kinase of Escherichia coli
Okazaki, R., & Kornberg, A. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51777-4 · Cited by 221
Recombineering: In Vivo Genetic Engineering in E. coli, S. enterica, and Beyond
Sawitzke, J. A., Thomason, L. C., Costantino, N., Bubunenko, M., Datta, S., & Court, D. L. (2007) · Methods in Enzymology · doi:10.1016/s0076-6879(06)21015-2 · Cited by 221
Neurological implications of urea cycle disorders
Gropman, A. L., Summar, M., & Leonard, J. V. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0709-5 · Cited by 218 · cited 7×
“Vomiting 0 0 0 0 0 1 (33) 2 (67) 0 0 1 (17) 0 0”
BackgroundInfluentialStandard Operating Procedures in Experimental Liver Research: Thioacetamide model in mice and rats
Wallace, M., Hamesch, K., Lunova, M., Kim, Y., Weiskirchen, R., Strnad, P., & Friedman, S. (2015) · Laboratory Animals · doi:10.1177/0023677215573040 · Cited by 210
Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice
Hanson, M. L., Hixon, J. A., Li, W., Felber, B. K., Anver, M. R., Stewart, C. A., Janelsins, B. M., Datta, S. K., Shen, W., McLean, M. H., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.060 · Cited by 195
Leonard, J. V., & Morris, A. A. M. (2002) · Seminars in Neonatology · doi:10.1053/siny.2001.0085 · Cited by 188
Engineering the gut microbiota to treat hyperammonemia
Shen, T.-C. D., Albenberg, L., Bittinger, K., Chehoud, C., Chen, Y.-Y., Judge, C. A., Chau, L., Ni, J., Sheng, M., Lin, A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79214 · Cited by 180 · cited 1×
“More re cently, a microbiomebased approach that replaces the gut microbiota with a defined consortium of bacteria with low urease activity has been explored in a preclinical model of hyperammonemia and showed prolonged lowering of colonic ammonia production and decreased mortality in mice (6).”
BackgroundReprogramming of anaerobic metabolism by the FnrS small RNA
Durand, S., & Storz, G. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07044.x · Cited by 171 · cited 1×
“Con trolling expression of argA215 anaerobically is an essential aspect of our strain design, and we selected PfnrS for its strong and specific activation under anaerobic conditions similar to those found in the colon (7, 49, 50).”
MethodRefining the Ammonia Hypothesis
Tapper, E. B., Jiang, Z. G., & Patwardhan, V. R. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.03.003 · Cited by 169 · cited 1×
“Elevated circulating ammonia not metabolized to urea by the liver can cross into the brain and induce astrocyte swelling, edema, and neurotoxicity through increased reactive oxy gen species and inflammatory responses (13).”
BackgroundCastanié-Cornet, M.-P., Cam, K., Bastiat, B., Cros, A., Bordes, P., & Gutierrez, C. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq097 · Cited by 145 · cited 1×
“coli, rpoS (56), heatshock protein genes [dnaKJE and groELS (57)], and multiple acid resistance genes [the glutamate decarboxylase genes gadA and gadB (58) and the glutaminase gene glsA (55)].”
BackgroundInsights from 100 years of research with probiotic E. coli
Wassenaar, T. M. (2016) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2016.00029 · Cited by 145
Biesecker, B. B., Ishibe, N., Hadley, D. W., Giambarresi, T. R., Kase, R. G., Lerman, C., & Struewing, J. P. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000814)93:4<313::aid-ajmg11>3.0.co;2-m · Cited by 136 · cited 6×
“UCDs are rare but serious and potentially fatal genetic diseases characterized by a deficiency in one of the six enzymes or two transporters necessary for the urea cycle to effectively metabolize waste nitrogen to urea (21).”
BackgroundInfluentialSplanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man.
Castillo, L., deRojas, T. C., Chapman, T. E., Vogt, J., Burke, J. F., Tannenbaum, S. R., & Young, V. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.193 · Cited by 133
Limaye, S. A., Haddad, R. I., Cilli, F., Sonis, S. T., Colevas, A. D., Brennan, M. T., Hu, K. S., & Murphy, B. A. (2013) · Cancer · doi:10.1002/cncr.28365 · Cited by 130 · cited 1×
“lactis strain producing trefoil factors has been studied for the treatment of oral mucositis (63).”
BackgroundL-Arginine is a precursor for nitrate biosynthesis in humans
Leaf, C. D., Wishnok, J. S., & Tannenbaum, S. R. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92325-5 · Cited by 129 · cited 1×
“4% depending on the route of adminis tration (oral or intragastric) (79, 80), and the proportion of urinary nitrate originating from dietary arginine is substantial (80).”
BackgroundKruis, W., Chrubasik, S., Boehm, S., Stange, C., & Schulze, J. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1363-9 · Cited by 128
NEOMYCIN IN THE TREATMENT OF HEPATIC COMA
Dawson, A. H. (1957) · The Lancet · doi:10.1016/s0140-6736(57)91544-1 · Cited by 123
Boysen, A., Møller-Jensen, J., Kallipolitis, B., Valentin-Hansen, P., & Overgaard, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.089755 · Cited by 116 · cited 2×
“Con trolling expression of argA215 anaerobically is an essential aspect of our strain design, and we selected PfnrS for its strong and specific activation under anaerobic conditions similar to those found in the colon (7, 49, 50).”
MethodComplete genome sequence of the Gram-negative probiotic Escherichia coli strain Nissle 1917
Reister, M., Hoffmeier, K., Krezdorn, N., Rotter, B., Liang, C., Rund, S. A., Dandekar, T., Sonnenborn, U., & Oelschlaeger, T. A. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.07.442 · Cited by 113
Interorgan ammonia trafficking in liver disease
Olde Damink, S. W. M., Jalan, R., & Dejong, C. H. C. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9122-5 · Cited by 111 · cited 1×
“Hyper ammonemia occurs when there is a defect in ammoniadetoxifying enzymes, such as in urea cycle disorders (UCDs), or when the liver is damaged, as in cirrhosis (19, 20).”
BackgroundHamady, Z. Z. R., Scott, N., Farrar, M. D., Wadhwa, M., Dilger, P., Whitehead, T. R., Thorpe, R., Holland, K. T., Lodge, P. J. A., & Carding, S. R. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21565 · Cited by 110
Hodges, P. E., & Rosenberg, L. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4142 · Cited by 102 · cited 8×
“UCDs are rare but serious and potentially fatal genetic diseases characterized by a deficiency in one of the six enzymes or two transporters necessary for the urea cycle to effectively metabolize waste nitrogen to urea (21).”
BackgroundInfluentialBosoi, C. R., Parent-Robitaille, C., Anderson, K. E., Tremblay, M., & Rose, C. F. (2011) · Hepatology · doi:10.1002/hep.24273 · Cited by 101 · cited 1×
“Investigational agents that may scavenge intestinal ammonia, such as AST120, a suspension of activated car bon microspheres acting as an ammonia adsorbent in the gut, have been explored preclinically and in patients with HE (35).”
BackgroundTRANSPORT OF UREA AND AMMONIA PRODUCTION IN THE HUMAN COLON
Wolpert, E., Phillips, S. F., & Summerskill, W. H. J. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90667-2 · Cited by 99
Safety and Effectiveness of Arginine in Adults
McNeal, C. J., Meininger, C. J., Reddy, D., Wilborn, C., & Wu, G. (2016) · Journal of Nutrition · doi:10.3945/jn.116.234740 · Cited by 99 · cited 8×
“UCDs are rare but serious and potentially fatal genetic diseases characterized by a deficiency in one of the six enzymes or two transporters necessary for the urea cycle to effectively metabolize waste nitrogen to urea (21).”
BackgroundInfluentialHepatocyte heterogeneity in glutamate uptake by isolated perfused rat liver
HÄUSSINGER, D., & GEROK, W. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07759.x · Cited by 90
Lu, C.-D., Winteler, H., Abdelal, A., & Haas, D. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.8.2459-2464.1999 · Cited by 89 · cited 2×
“Downregulation of arcABCD is consistent with its positive regula tion by ArgR, as observed in other bacterial species (54, 55).”
BackgroundEvaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions
Suraweera, D., Sundaram, V., & Saab, S. (2016) · Gut and Liver · doi:10.5009/gnl15419 · Cited by 82 · cited 2×
“The longstanding evidence for the importance of intestinally generated ammonia and the observation that antibiotic treatment can lower systemic and portal ammonia (31–33) have led to the clinical development of therapeutic agents aimed at decreasing gut microbial activity or adsorbing colonic ammonia for the treatmen…”
BackgroundKim, Y., Ejaz, A. M., Tayal, A., Spolverato, G., Bridges, J. F. P., Anders, R. A., & Pawlik, T. M. (2014) · Cancer · doi:10.1002/cncr.28843 · Cited by 71 · cited 1×
“The more se vere form of HE, referred to as overt HE, is associated with obvious mental disorientation and physical symptoms (for example, asterixis, lethargy, seizures, tremors, stupor, or coma) that arise over several days or hours and may be fatal (26).”
BackgroundFulde, M., Willenborg, J., de Greeff, A., Benga, L., Smith, H. E., Valentin-Weigand, P., & Goethe, R. (2011) · Microbiology · doi:10.1099/mic.0.043067-0 · Cited by 70
Serum Ammonia Level for the Evaluation of Hepatic Encephalopathy
Ge, P. S., & Runyon, B. A. (2014) · JAMA · doi:10.1001/jama.2014.2398 · Cited by 65 · cited 1×
“Increased arterial and venous ammonia concentrations correlated with increased HE severity, with concentrations above 100 M in addition to model for endstage liver disease (MELD) scores above 32 that are predictive of an onset of an episode of HE with 94% specificity and 74% accuracy (29, 30).”
BackgroundBiomarkers of Arginine and Lysine Excess
Luiking, Y. C., & Deutz, N. E. P. (2007) · Journal of Nutrition · doi:10.1093/jn/137.6.1662s · Cited by 60 · cited 1×
“Arginine metabolism is complex, as arginine can be converted into several metabolites, including citrulline, ornithine, proline, and nitric oxide (59).”
BackgroundRajagopal, B. S., DePonte, J., Tuchman, M., & Malamy, M. H. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.5.1805-1811.1998 · Cited by 56
Mariotti, F., Petzke, K. J., Bonnet, D., Szézépanski, I., Bos, C., Huneau, J., & Fouillet, H. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.048025 · Cited by 56 · cited 2×
“Arginine can be metabolized by nitric oxide synthase, resulting in production of nitric oxide and citrulline (78), and ultimately excretion of nitrate in urine.”
BackgroundResultHepatocyte heterogeneity in glutamate metabolism and bidirectional transport in perfused rat liver
Häussinger, D., STOLL, B., Stehlé, T., & Gerok, W. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb15101.x · Cited by 49
In vivo nitrogen metabolism in ornithine transcarbamylase deficiency.
Yudkoff, M., Daikhin, Y., Nissim, I., Jawad, A. F., Wilson, J. M., & Batshaw, M. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119023 · Cited by 44
Kurtz, C., Denney, W. S., Blankstein, L., Guilmain, S. E., Machinani, S., Kotula, J., Saha, S., Miller, P., & Brennan, A. M. (2018) · Clinical and Translational Science · doi:10.1111/cts.12528 · Cited by 43 · cited 3×
“Similarly, after daily repeated oral gavage dose administration of the related strain SYNB1020KR to female cynomolgus monkeys, SYNB1020KR demonstrated clearance within 7 days of the last dose [as previously reported (40)].”
BackgroundMethodInfluentialSelf-citationPhear, E. A., & Ruebner, B. H. (1956) · PubMed Central · Cited by 41
Porcine intestinal ammonia liberation
van Berlo, C. L. H., van Leeuwen, P. A. M., & Soeters, P. B. (1988) · Journal of Hepatology · doi:10.1016/s0168-8278(88)80489-6 · Cited by 30
Zhao, G., Jin, Z., Allewell, N. M., Tuchman, M., & Shi, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070369 · Cited by 26 · cited 1×
“To maximize arginine production and prevent inhibitory feedback, we deleted the gene encoding the arginine repressor ArgR and then in tegrated the gene argA215, encoding ArgAY19C, a feedbackresistant version of the Nacetylglutamate synthase enzyme ArgA (argAfbr) (36, 47, 48), into the intergenic region separating t…”
MethodMechanism of arginine regulation of acetylglutamate synthase, the first enzyme of arginine synthesis
Sancho‐Vaello, E., Fernández-Murga, M. L., & Rubio, V. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.12.001 · Cited by 26 · cited 1×
“To maximize arginine production and prevent inhibitory feedback, we deleted the gene encoding the arginine repressor ArgR and then in tegrated the gene argA215, encoding ArgAY19C, a feedbackresistant version of the Nacetylglutamate synthase enzyme ArgA (argAfbr) (36, 47, 48), into the intergenic region separating t…”
MethodOxidative stress in urea cycle disorders: Findings from clinical and basic research
Parmeggiani, B., & Vargas, C. R. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.041 · Cited by 25 · cited 1×
“Hyperammonemia can induce cerebral edema, energy failure, neurotransmitter alterations, reactive oxygen species, or inflamma tion (67, 68), and although we did not directly explore these mech anisms in this study, it is possible that SYNB1020 and SYNB1020KR enhanced survival by decreasing these ammoniainduced effec…”
BackgroundAntibiotic Therapy in the Management of Hepatic Coma
Fast, B. (1958) · Archives of Internal Medicine · doi:10.1001/archinte.1958.00260140299041 · Cited by 24
Factors Affecting Compliance and Persistence with Treatment for Hepatic Encephalopathy
Neff, G. W. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.pt2.22s · Cited by 20 · cited 1×
“Therefore, the limitations in current standard of care treatments for hyperam monemia and the lack of new agents highlight the need for develop ment of a safe, welltolerated, and effective treatment to improve outcomes for conditions such as UCD and HE (37, 38).”
BackgroundConsiderations for the cost-effective management of hepatic encephalopathy.
Flamm, S. L. (2018) · PubMed · Cited by 20
Imler, M., Chabrier, G., Simon, C., & Schlienger, J.-L. (1988) · Research in Experimental Medicine · doi:10.1007/bf01852088 · Cited by 8 · cited 1×
“Similar quantities of ammonia are generated in the small and large intestine (10), but the mechanisms of ammonia generation differ.”
BackgroundDagon, Y., Millet, Y. A., Renaud, L., Ha, B., Wong, D., Castillo, M., Thomas, J., Lora, J. M., Miller, P., & Kurtz, C. B. (2018) · Gastroenterology · doi:10.1016/s0016-5085(18)33591-1 · Cited by 1
Self-citation
Research works printed but not linked: 1
- 10.1128/mr.53.1.85-108.1989 · doi:10.1128/mr.53.1.85-108.1989 · Paper page
Cited by
Salminen, S., Collado, M. C., Endo, A., Hill, C., Lebeer, S., Quigley, E. M. M., Sanders, M. E., Shamir, R., Swann, J. R., Szajewska, H., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00440-6 · Cited by 2,488
Swanson, K. S., Gibson, G. R., Hutkins, R., Reimer, R. A., Reid, G., Verbeke, K., Scott, K. P., Holscher, H. D., Azad, M. B., Delzenne, N. M., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0344-2 · Cited by 2,196
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
The gut–liver axis and gut microbiota in health and liver disease
Hsu, C. L., & Schnabl, B. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00904-3 · Cited by 737
Zhou, J., Li, M., Chen, Q., Li, X., Chen, L., Dong, Z., Zhu, W., Yang, Y., Liu, Z., & Chen, Q. (2022) · Nature Communications · doi:10.1038/s41467-022-31171-0 · Cited by 695
Metadata
- Authors
- Kurtz, C. B., Millet, Y. A., Puurunen, M. K., Perreault, M., Charbonneau, M. R., Isabella, V. M., Kotula, J. W., Antipov, E., Dagon, Y., Denney, W. S., Wagner, D. A., West, K. A., Degar, A. J., Brennan, A. M., & Miller, P. F.
- Affiliations
- Synlogic (United States) (US)
- Diversigen Inc., 1 Baylor Plaza, Houston, TX 77030, USA.
- Metabolic Solutions (US)
- Corresponding author
- Kurtz, Caroline B.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2019-01-16
- Volume
- 11
- Issue
- 475
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2910587862
- Cited by
- 399
- References
- 89
- Citations by year
- 2026: 53 · 2025: 54 · 2024: 66 · 2023: 50 · 2022: 58 · 2021: 55 · 2020: 43 · 2019: 20
- FWCI
- 24.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- hyperammonemia, urea cycle disorders, hepatic encephalopathy, fecal excretion, probiotic therapy
- MeSH terms
- Ammonia, Animals, Arginine, Disease Models, Animal, Escherichia coli, Feces, Female, Genetic Engineering, Humans, Macaca fascicularis, Male, Nitrates, Stress, Physiological, Survival Analysis, Hyperammonemia, Mice, Biosynthetic Pathways, Healthy Volunteers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.